HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Arcadia Biosciences (NASDAQ:RKDA), maintaining a $10 price target.
April 05, 2024 | 10:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reiterates a Buy rating on Arcadia Biosciences, with a maintained price target of $10.
The reiteration of a Buy rating and the maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. could instill confidence in investors and potentially lead to a positive short-term impact on RKDA's stock price. The analyst's bullish stance suggests a strong belief in the company's future performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100